Different Technologies for Obtaining Pneumococcal Immunogens
Relevance. The worldwide use of pneumococcal vaccines, in particular conjugated vaccines (PCV), has led to a significant reduction in the incidence of invasive pneumococcal diseases in both vaccinated children and unvaccinated people of all ages. However, "non-vaccine" serotypes and capsul...
Saved in:
| Main Authors: | I. M. Gruber, O. M. Kukina, N. B Egorova, O. V. Zhigunova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2021-03-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/1184 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01) -
EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01) -
A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics
by: Aurelija Petrutienė, et al.
Published: (2025-08-01) -
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10)
by: Veronika Jotterand, et al.
Published: (2025-03-01) -
Experimental Protein-Containing Preparations <i>Streptococcus pneumoniae</i>, Obtained from Fresh Isolated Strains and Museum
by: O. M. Kukina, et al.
Published: (2020-03-01)